Výsledky vyhledávání - "Nancy M. Dougherty"

Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits

Autor: Halea A. Corcoran, Nancy M. Dougherty, Elizabeth P. Baskin, David B. Gilberto, Xianzhi Mao, James C. Hershey, Jacquelynn J. Cook, Andrew J. Bett, Kenneth A. Thomas

Publikováno v: Heart and Vessels. 18:142-149

This study was designed to test the ability of adenovirus-delivered vascular endothelial growth factor (Ad-VEGF) to stimulate angiogenesis and arteriogenesis in the rabbit hindlimb following the induction of ischemia and to evaluate the functional ch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4751ff7a9b4fb98f7d6b3ad901b3860c
https://doi.org/10.1007/s00380-003-0694-z

Zobrazit plný text záznamu

Fine-scale transgenic mapping of the MyoD core enhancer: MyoD is regulated by distinct but overlapping mechanisms in myotomal and non-myotomal muscle lineages

Autor: Nancy M. Dougherty, Cheri M. Love, David J. Goldhamer, Kristen L. Kucharczuk

Publikováno v: Development. 126:1957-1965

Skeletal muscle lineage determination is regulated by the myogenic regulatory genes, MyoD and Myf-5. Previously, we identified a 258 bp core enhancer element 20 kb 5′ of the MyoD gene that regulates MyoD gene activation in mouse embryos. To elucida

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64049e0793e9449aa1ff3b723553703e
https://doi.org/10.1242/dev.126.9.1957

Zobrazit plný text záznamu

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines

Autor: Mary-Ellen Davies, Paul M. Keller, Mark D. Yeager, Danilo R. Casimiro, Nancy M. Dougherty, Laura L. Franlin, John W. Shiver, Elayne C. Dell, Andrew J. Bett, Philip S. Bennett, Helen C. Perry, Fubao Wang, Miguel Aste-Amezaga, Joseph M. Antonello, Deepa K. Patel

Publikováno v: Human gene therapy. 15(3)

Replication-defective recombinant adenoviruses (rAd) are used as vectors for vaccines as well as for gene therapy. To determine type-specific antibodies to adenovirus (Ad) serotypes 2, 5, 24, 34, and 35, we developed quantitative neutralization assay

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11a76d06911397110a79b8bc271080de
https://pubmed.ncbi.nlm.nih.gov/15018738

Zobrazit plný text záznamu

Akademický článek

Quantitative Adenovirus Neutralization Assays Based on the Secreted Alkaline Phosphatase Reporter Gene: Application in Epidemiologic Studies and in the Design of Adenovector Vaccines.

Autor: Miguel Aste-Amézaga, Andrew J. Bett, Fubao Wang, Danilo R. Casimiro, Joseph M. Antonello, Deepa K. Patel, Elayne C. Dell, Laura L. Franlin, Nancy M. Dougherty, Philip S. Bennett, Helen C. Perry, Mary-Ellen Davies, John W. Shiver, Paul M. Keller, Mark D. Yeager

Publikováno v: Human Gene Therapy; 3/01/2004, Vol. 15 Issue 3, p293-304, 12p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání